US Broker Ratings

Genmab A/S (GMAB) Stock Analysis: A Biotech Powerhouse with 29.55% Potential Upside

For investors with an eye on the healthcare sector, Genmab A/S (NASDAQ: GMAB) presents a compelling opportunity within the biotechnology industry. Headquartered in Copenhagen, Denmark, Genmab..

Medtronic plc (MDT) Stock Analysis: Exploring a 15.39% Upside Potential in the Healthcare Sector

Medtronic plc (MDT), a behemoth in the healthcare sector with a market capitalization of $124.23 billion, stands as a pivotal player in the medical devices industry...

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: Exploring Growth Potential in the Medical Devices Sector

Smith & Nephew SNATS, Inc. (NYSE: SNN), a major player in the global medical devices market, is drawing attention from investors with its promising growth prospects..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: Navigating a -0.37% Potential Downside Amidst Global Expansion

Dr. Reddy’s Laboratories Ltd (NYSE: RDY), a prominent player in the healthcare sector, operates as a leading pharmaceutical company with a robust presence in North America,..

ICON plc (ICLR) Stock Analysis: Exploring the 58% Potential Upside in the Healthcare Sector

ICON plc (NASDAQ: ICLR), a prominent player in the healthcare sector, stands as a beacon of interest for investors looking to capitalize on the healthcare industry’s..

Regeneron Pharmaceuticals (REGN) Stock Analysis: Navigating Growth with a Promising 11.58% Upside

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) stands as a prominent player in the biotechnology sector, consistently pioneering advancements in healthcare through the discovery and commercialization of innovative..

Biogen Inc. (BIIB) Stock Analysis: Gauging the 6.67% Potential Upside Amidst a Challenging Revenue Landscape

Biogen Inc. (BIIB), a titan in the healthcare sector, is a prominent player in the drug manufacturing industry, with a market capitalization of $28.18 billion. Despite..

Zoetis Inc. (ZTS) Stock Analysis: Unveiling a 17.25% Potential Upside in the Animal Health Giant

Zoetis Inc. (NYSE: ZTS), a prominent player in the healthcare sector specializing in the animal health industry, continues to capture investor interest with its robust market..

Haleon plc (HLN) Stock Analysis: A Look at Growth Potential and Analyst Ratings

Haleon plc, trading under the ticker HLN, represents a prominent player in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. Headquartered in..

The Cooper Companies, Inc. (COO) Stock Analysis: Healthcare Giant with an 8.24% Upside Potential

The Cooper Companies, Inc. (NYSE: COO), a stalwart in the healthcare sector, operates within the medical instruments and supplies industry, primarily focusing on contact lenses and..

AstraZeneca PLC (AZN) Stock Analysis: Navigating a -19.37% Potential Downside Amidst Robust Dividend Yield

AstraZeneca PLC (NASDAQ: AZN), a formidable player in the healthcare sector, commands a notable market capitalization of $316.57 billion. This UK-based biopharmaceutical giant is renowned for..

Tenet Healthcare Corporation (THC) Stock Analysis: Exploring a Promising 11.79% Upside in the Healthcare Sector

Tenet Healthcare Corporation (NYSE: THC) is making waves in the healthcare sector, capturing the attention of investors with its robust growth metrics and a compelling potential..

Takeda Pharmaceutical (TAK): Investor Outlook on Robust Revenue Growth and Strong Analyst Ratings

As one of the oldest and most established players in the global pharmaceutical landscape, Takeda Pharmaceutical Company Limited (NYSE: TAK) continues to capture the attention of..

Hologic, Inc. (HOLX) Stock Analysis: A Steady Performer in the Healthcare Sector

As investors navigate the ever-evolving landscape of the healthcare sector, Hologic, Inc. (NASDAQ: HOLX) stands out as a robust player, specializing in medical instruments and supplies..

Waters Corporation (WAT) Stock Analysis: Unlocking 19.42% Potential Upside in the Healthcare Diagnostics Sector

Investors eyeing opportunities in the healthcare diagnostics sector may find Waters Corporation (NYSE: WAT) an intriguing prospect. With a market capitalization of $32.7 billion, Waters Corporation..

Gilead Sciences, Inc. (GILD) Stock Report: Navigating Market Dynamics with a 2.17% Dividend Yield

Gilead Sciences, Inc. (NASDAQ: GILD) stands as a formidable player in the healthcare sector, particularly within the realm of biopharmaceuticals. With a current market capitalization of..

Bristol-Myers Squibb (BMY) Stock Analysis: Unpacking the Healthcare Giant’s Potential Upside

For investors eyeing the healthcare sector, Bristol-Myers Squibb Company (NYSE: BMY) presents a compelling case with its robust portfolio and strategic positioning in the drug manufacturing..

Sanofi (SNY) Investor Outlook: High Dividend Yield with 23% Upside Potential

Sanofi (SNY), the French pharmaceutical giant, is a prominent player in the healthcare sector, specifically within the drug manufacturing industry. With a market capitalization of $113.57..

Stryker Corporation (SYK) Stock Analysis: Unpacking the 11.62% Potential Upside for Savvy Investors

Stryker Corporation (NYSE: SYK), a titan in the healthcare sector, is a key player within the medical devices industry, boasting a substantial market capitalization of $145.51..

Cencora, Inc. (COR) Stock Analysis: A Healthcare Heavyweight with 11.83% Potential Upside

Cencora, Inc. (COR), a titan in the healthcare sector, has been making waves in the medical distribution industry with a market capitalization of $70.24 billion. As..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds